Mitochondria-rich cytochalasomes as an intravenously deliverable vesicle platform for ischemic heart disease.
- DOI
- 10.1016/j.bioactmat.2026.09.036
- Published
- 2027 Mar
- Container
- Bioactive materials
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bioactmat.2026.09.036,
title = {Mitochondria-rich cytochalasomes as an intravenously deliverable vesicle platform for ischemic heart disease.},
author = {Gao X and Zhang L and Xu L and Jin Y and Qian B and Zhang Y and Li M and Yuan Z and Lu Y and Qiu N and Wang P and Sun X and Ge J and Sun A},
year = {2027},
journal = {Bioactive materials},
doi = {10.1016/j.bioactmat.2026.09.036},
url = {https://doi.org/10.1016/j.bioactmat.2026.09.036}
}RIS
TY - JOUR TI - Mitochondria-rich cytochalasomes as an intravenously deliverable vesicle platform for ischemic heart disease. AU - Gao X AU - Zhang L AU - Xu L AU - Jin Y AU - Qian B AU - Zhang Y AU - Li M AU - Yuan Z AU - Lu Y AU - Qiu N AU - Wang P AU - Sun X AU - Ge J AU - Sun A PY - 2027 JO - Bioactive materials DO - 10.1016/j.bioactmat.2026.09.036 UR - https://doi.org/10.1016/j.bioactmat.2026.09.036 ER -
APA
X, G., L, Z., L, X., Y, J., B, Q., Y, Z., M, L., Z, Y., Y, L., N, Q., P, W., X, S., J, G., & A, S. (2027). Mitochondria-rich cytochalasomes as an intravenously deliverable vesicle platform for ischemic heart disease.. Bioactive materials. https://doi.org/10.1016/j.bioactmat.2026.09.036
Source records
- pubmed · retrieved 2026-11-10T11:34:35.165Z